Compare TMDX & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMDX | PRVA |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.7B |
| IPO Year | 2019 | 2021 |
| Metric | TMDX | PRVA |
|---|---|---|
| Price | $78.56 | $23.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | ★ $148.22 | $31.17 |
| AVG Volume (30 Days) | ★ 1.1M | 848.4K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 382.18 | 63.64 |
| EPS | ★ 0.20 | 0.02 |
| Revenue | $605,494,000.00 | ★ $2,122,842,000.00 |
| Revenue This Year | $24.25 | $18.19 |
| Revenue Next Year | $18.75 | $10.72 |
| P/E Ratio | ★ $394.55 | $1,178.00 |
| Revenue Growth | ★ 37.13 | 22.26 |
| 52 Week Low | $60.11 | $18.78 |
| 52 Week High | $156.00 | $26.51 |
| Indicator | TMDX | PRVA |
|---|---|---|
| Relative Strength Index (RSI) | 56.11 | 60.32 |
| Support Level | $64.90 | $23.05 |
| Resistance Level | $120.60 | $24.14 |
| Average True Range (ATR) | 4.22 | 0.56 |
| MACD | 1.88 | 0.26 |
| Stochastic Oscillator | 87.80 | 95.68 |
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.